First Quadrant’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-28,324
Closed -$2.81M 635
2019
Q3
$2.81M Sell
28,324
-12,769
-31% -$1.21M 0.26% 96
2019
Q2
$3.8M Hold
41,093
0.26% 89
2019
Q1
$3.88M Sell
41,093
-10,934
-21% -$956K 0.3% 75
2018
Q4
$3.33M Buy
52,027
+1,072
+2% +$79.1K 0.27% 87
2018
Q3
$4.56M Sell
50,955
-122,458
-71% -$10.8M 0.1% 216
2018
Q2
$13.8M Sell
173,413
-276,534
-61% -$23M 0.26% 127
2018
Q1
$40.1M Buy
449,947
+185,775
+70% +$17.8M 0.77% 13
2017
Q4
$27.6M Hold
264,172
0.52% 45
2017
Q3
$38.5M Sell
264,172
-5,038
-2% -$686K 0.75% 13
2017
Q2
$35M Buy
269,210
+167,394
+164% +$20.5M 0.7% 16
2017
Q1
$12.7M Buy
101,816
+17,273
+20% +$2.07M 0.25% 151
2016
Q4
$9.79M Buy
84,543
+3,804
+5% +$424K 0.2% 170
2016
Q3
$8.44M Buy
80,739
+139
+0.2% +$15K 0.18% 183
2016
Q2
$7.95M Buy
80,600
+8,400
+12% +$869K 0.18% 170
2016
Q1
$7.23M Buy
72,200
+1,200
+2% +$124K 0.16% 182
2015
Q4
$8.5M Sell
71,000
-2,500
-3% -$289K 0.19% 158
2015
Q3
$7.95M Sell
73,500
-36,700
-33% -$4.55M 0.18% 158
2015
Q2
$12.8M Buy
110,200
+18,500
+20% +$2.11M 0.27% 121
2015
Q1
$10.6M Buy
91,700
+17,900
+24% +$2.14M 0.22% 136
2014
Q4
$8.26M Buy
73,800
+300
+0.4% +$31.6K 0.17% 156
2014
Q3
$6.97M Sell
73,500
-142,100
-66% -$12.8M 0.16% 159
2014
Q2
$18.5M Hold
215,600
0.41% 71
2014
Q1
$15M Sell
215,600
-91,400
-30% -$7.24M 0.34% 90
2013
Q4
$25.9M Buy
307,000
+167,000
+119% +$13.2M 0.61% 46
2013
Q3
$10.8M Hold
140,000
0.27% 115
2013
Q2
$8.19M Buy
+140,000
New +$8.42M 0.22% 142

Other funds holding CELG

First Quadrant's CELG Position: Q4 2019 in Review

First Quadrant sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 28,324 shares — an estimated $2.81M sold.

First Quadrant first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $40.1M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • First Quadrant reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • First Quadrant sold 28,324 Celgene Corp shares in Q4 2019, an estimated $2.81M.
  • First Quadrant first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • First Quadrant's Celgene Corp position peaked at $40.1M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on First Quadrant's 13F filing for Q4 2019, filed 28 Jan 2020.